NCT05829421Completed
Addressing Problems in Managing Daily Tasks Due to Poststroke Cognitive Impairments
Feasibility of a Neuropsychologically Informed Occupational Therapy Intervention Targeting Decreased Ability to Perform Activities of Daily Living in People With Poststroke Cognitive Impairment
Source: ClinicalTrials.gov · Last updated 5 Dec 2025
Brief summary (registry, in English)
The purpose of this study is to investigate feasibility aspects of an intervention targeting problems in managing daily tasks due to mild-to-moderate poststroke cognitive impairments. We will specifically address uncertainties related to intervention content and delivery, and trial design and conduct.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 6 Mar 2023
- Start date
- 25 May 2023
- Primary completion date
- 29 Mar 2024
- Lead sponsor
- Emma Ghaziani
- Diseases
- Stroke
- NCT number
- NCT05829421
What you commit to
- Study type: Interventional
- Participants enrolled: 8
- From 25 May 2023 to the primary completion date, 29 Mar 2024
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- psychiatric conditions causing difficulties or preventing participation, as evaluated by the recruiting health care professional(s)
Other
- communication problems causing difficulties or preventing participation, as evaluated by the recruiting healthcare professional(s)
- CAREGIVERS:
- -communication problems or other issues causing difficulties in participation as evaluated by the recruiting healthcare professional(s).
- Patients without a close carer will not be excluded.
- CLINICAL STAFF:
- \- unable to to follow a preliminary English version of the intervention manual.
Who the study is looking for
- first-ever symptomatic stroke,
- age ≥ 18 years,
- residence in Frederiksberg Municipality, Denmark,
- independent in pre-stroke everyday life (≤ 2 points on the modified Rankin Scale, mRS),
- experiencing problems in performing ADLs due to cognitive impairment; these problems are expected to still be present at hospital discharge,
- medical condition allows commencement of rehabilitation focused on ADL and cognition
- fully aware or mild-to-moderate unawareness of deficits (≤ 2 points on the Bisiach Anosognosia Scale, BAS),
- a global cognitive function corresponding to ≥ 17 points on the Montreal Cognitive Assessment, MoCA,
- ≤ 10 points on the depression subscale of the Hospital Anxiety and Depression Scale, HADS,
- able to provide informed consent, as evaluated by the recruiting healthcare professional(s),
- logistically possible to perform baseline assessments and create an individualised intervention plan during hospital stay
- provides informed consent
- appointed as close carer (by a patient who consented to participate),
- age ≥18y,
- provides informed consent.
- appointed as local project managers, or OTs or NPs who conduct assessments or deliver the intervention in the participating centres,
- provides informed consent.
Criteria the registry did not label
- PATIENTS:
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bispebjerg and Frederiksberg Hospital Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
| the Inpatient Rehabilitation Centre Coordinator of this site? Confirm its status | Frederiksberg | Denmark | Unknown status |
| Neurorehabilitation Centre Østervang Coordinator of this site? Confirm its status | Frederiksberg | Denmark | Unknown status |
| the Day Rehabilitation Centre Coordinator of this site? Confirm its status | Frederiksberg | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.